Press Release Summary = IT.Omics, provider of the LS-Graph® network analysis software, and OmniViz, Inc., a leading provider of software and components for visual mining of complex data, announced a collaboration which aims to increase creativity and efficiency in the drug development process.
Press Release Body = Lille (France) - December 7, 2005 - IT.Omics, provider of the LS-Graph® network analysis software, and OmniViz, Inc., a leading provider of software and components for visual mining of complex data, announced a collaboration during the European Biotech Crossroads meeting last week. The collaboration aims to increase creativity and efficiency in the drug development process through a tighter coupling of advanced visualization and analysis of experimental data with knowledge-based data mining and the building of systems biology networks.
IT.Omics' LS-Graph® technology consists of automated information extraction for the generation of global knowledge graphs from various sources, with a coverage and flexibility beyond that of standard curated databases. Providing critical insight into regulatory mechanisms, the resulting networks help researchers focus on high value-added targets as well as better understand mechanisms of action and side effects.
The OmniViz® software provides unique high-level visualization of multi-dimensional data enabling researchers to better characterize their results, discover novel relationships, and test emerging hypotheses. Typical sources of input include biological and chemical experimental data, toxicology results, clinical trial and marketing information, as well as the global biomedical and patent literature.
"Enabling users of LS-Graph® to seamlessly couple into the unique OmniViz visualization and mining software will expand the scope of LS-Graph and provide a framework that supports rapid and more efficient decision-making," said Emmanuel Jospin, CEO of IT.Omics. "The extensive knowledge extraction and analysis represented by LS-Graph® provides a synergistic framework for the interpretation of relationships observed in OmniViz® visualizations," said Jeffrey D. Saffer, President of OmniViz, Inc.
About IT.Omics
IT.Omics (http://www.it-omics.com) is a Lille, France-based bioinformatics company dedicated to the design and development of integrated bioinformatics solutions that enhance the drug development process. Utilizing state-of-the-art technologies of data mining, data analysis and knowledge management, these solutions help better understand the pathogenesis of disease and drug mechanisms of action, select and prioritize therapeutic targets and drug candidates, access key sources of information fast and easy, both "system-oriented" (i.e., focused on networks among biological entities) and contextualized to their fields of interest.
About OmniViz, Inc. OmniViz, Inc. (http://www.omniviz.com), is a leader in the mining and visualization of vast and disparate data sets for faster and more efficient decision-making. Its proprietary technologies provide Visual Intelligence, enabling analysis of the very large and varied sorts of data sets currently at the disposal of researchers in large discovery organizations, leading to increased productivity, decreasing time to market, and reducing business risks.
LS-Graph is a registered trademark of IT.Omics OmniViz is a registered trademark of OmniViz, Inc.
2025
